313 related articles for article (PubMed ID: 31130119)
1. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment].
Kırdar S; Yaşa MH; Sayan M; Aydın N
Mikrobiyol Bul; 2019 Apr; 53(2):144-155. PubMed ID: 31130119
[TBL] [Abstract][Full Text] [Related]
2. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues].
Sayan M; Buğdacı MS
Mikrobiyol Bul; 2013 Jul; 47(3):544-9. PubMed ID: 23971933
[TBL] [Abstract][Full Text] [Related]
3. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
Sayan M; Akhan SC
Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
[TBL] [Abstract][Full Text] [Related]
4. Mutations in Pol gene of hepatitis B virus in patients with chronic hepatitis B before and after therapy with nucleoside/nucleotide analogues.
Januszkiewicz-Lewandowska D; Rucka A; Kowala-Piaskowska A; Bereszynska I; Mozer-Lisewska I; Zajac-Spychala O; Wysocki J; Nowak J
Acta Virol; 2014; 58(2):185-9. PubMed ID: 24957725
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the
Arikan A; Sayan M; Sanlidag T; Suer K; Akcali S; Guvenir M
Pol J Microbiol; 2019 Sep; 68(3):317-322. PubMed ID: 31880877
[TBL] [Abstract][Full Text] [Related]
6. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations.
Choe WH; Kim K; Lee SY; Choi YM; Kwon SY; Kim JH; Kim BJ
World J Gastroenterol; 2019 Sep; 25(33):4985-4998. PubMed ID: 31543688
[TBL] [Abstract][Full Text] [Related]
8. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
[TBL] [Abstract][Full Text] [Related]
9. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
Kazim SN; Sarin SK; Sharma BC; Khan LA; Hasnain SE
Intervirology; 2006; 49(3):152-60. PubMed ID: 16428891
[TBL] [Abstract][Full Text] [Related]
10. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.
Chen CH; Lee CM; Tung WC; Wang JH; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS
J Hepatol; 2010 Apr; 52(4):478-85. PubMed ID: 20185198
[TBL] [Abstract][Full Text] [Related]
11. HBV mutations associated with lamivudine therapy.
Lapiński TW; Parfieniuk-Kowerda A; Trzos A; Jaroszewicz J; Kowalczuk O; Nikliński J; Flisiak R
Przegl Epidemiol; 2013; 67(4):611-6, 705-8. PubMed ID: 24741905
[TBL] [Abstract][Full Text] [Related]
12. [Determination of reverse transcriptase inhibitor nucleoside analogue resistance profile in pretreatment phase of patients with viral hepatitis B].
Öksüz Z; Serin MS; Serin A; Sezgin O; Gonca S
Mikrobiyol Bul; 2019 Apr; 53(2):156-169. PubMed ID: 31130120
[TBL] [Abstract][Full Text] [Related]
13. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
[TBL] [Abstract][Full Text] [Related]
14. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
Torresi J; Earnest-Silveira L; Civitico G; Walters TE; Lewin SR; Fyfe J; Locarnini SA; Manns M; Trautwein C; Bock TC
Virology; 2002 Jul; 299(1):88-99. PubMed ID: 12167344
[TBL] [Abstract][Full Text] [Related]
15. Molecular Epidemiology of Hepatitis B Virus in Turkish Cypriot.
Sumer U; Sayan M
Pol J Microbiol; 2019 Dec; 68(4):449-456. PubMed ID: 31880889
[TBL] [Abstract][Full Text] [Related]
16. Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.
Mantovani N; Cicero M; Santana LC; Silveira C; do Carmo EP; Abrão PR; Diaz RS; Caseiro MM; Komninakis SV
Virol J; 2013 Oct; 10():320. PubMed ID: 24165277
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome.
Amini-Bavil-Olyaee S; Herbers U; Mohebbi SR; Sabahi F; Zali MR; Luedde T; Trautwein C; Tacke F
J Hepatol; 2009 Oct; 51(4):647-54. PubMed ID: 19586679
[TBL] [Abstract][Full Text] [Related]
18. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy.
Yeh CT
Antivir Ther; 2010; 15(3 Pt B):471-5. PubMed ID: 20516567
[TBL] [Abstract][Full Text] [Related]
19. Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B.
Lei J; Wang Y; Wang LL; Zhang SJ; Chen W; Bai ZG; Xu LY
Virol J; 2013 Oct; 10():313. PubMed ID: 24160943
[TBL] [Abstract][Full Text] [Related]
20. [Mutations of HBV polymerase gene sequence in lamivudine-resistant chronic hepatitis B patients].
Wang C; Sun J; Chen JJ; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):729-30. PubMed ID: 18504191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]